I. Hirano

P. Kahrilas, I. Hirano, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Effectiveness of esophageal dilation for symptomatic cricopharyngeal bar.

P. Kahrilas, I. Hirano, Andrew Y. Wang, 2005, Gastrointestinal endoscopy.

Blockade of the interaction between BMP9 and endoglin on erythroid progenitors promotes erythropoiesis in mice

I. Hirano, R. Shimizu, H. Ariyama, 2021, Genes to cells : devoted to molecular & cellular mechanisms.

Contributions From Gastroenterology: Acid Peptic Disorders, Barrett's Esophagus and Eosinophilic Esophagitis.

J. Rubenstein, R. Souza, I. Hirano, 2018, Gastroenterology.

THE EOE ROLLER

J. Richter, I. Hirano, 2014 .

Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review

A. Bredenoord, A. Schoepfer, A. Straumann, 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes

K. Takeda, Masayuki Yamamoto, T. Miyata, 2015, Molecular and Cellular Biology.

Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS)

J. Woosley, M. Vieth, E. Savarino, 2021, The Journal of allergy and clinical immunology.

Eosinophilic esophagitis--emerging epidemic or misdiagnosed malady?

I. Hirano, A. Gawron, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Future Directions in Eosinophilic Esophagitis.

I. Hirano, 2018, Gastrointestinal endoscopy clinics of North America.

An immortalized cell line derived from renal erythropoietin-producing (REP) cells demonstrates their potential to transform into myofibroblasts

S. Ito, Masayuki Yamamoto, I. Hirano, 2019, Scientific Reports.

Advances in the endoscopic evaluation of eosinophilic esophagitis

I. Hirano, L. Kia, 2016, Current opinion in gastroenterology.

Emerging drugs for eosinophilic esophagitis

I. Hirano, E. Kern, 2013, Expert opinion on emerging drugs.

Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings

Masayuki Yamamoto, I. Hirano, Atsushi Hasegawa, 2017, Genes to cells : devoted to molecular & cellular mechanisms.

Erythropoietin production in neuroepithelial and neural crest cells during primitive erythropoiesis

Masayuki Yamamoto, I. Hirano, N. Minegishi, 2013, Nature Communications.

Symptomatic and physiologic outcomes one year after peroral esophageal myotomy (POEM) for treatment of achalasia

Ezra N. Teitelbaum, J. Pandolfino, N. Soper, 2014, Surgical Endoscopy.

Esophagogastric junction distensibility measurements during Heller myotomy and POEM for achalasia predict postoperative symptomatic outcomes

Ezra N. Teitelbaum, J. Pandolfino, N. Soper, 2014, Surgical Endoscopy.

Pathophysiology of achalasia and diffuse esophageal spasm

I. Hirano, 2006 .

Deaths after living related liver transplantation

I. Hirano, A. Blei, 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

Sanjiv J. Shah, M. Gheorghiade, A. Morgan, 2011, The Lancet.

Esophagogastric Junction Morphology Predicts Susceptibility to Exercise-Induced Reflux

Laura K. Bianchi, J. Pandolfino, P. Kahrilas, 2004, American Journal of Gastroenterology.

Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.

J. Murray, E. Dellon, G. Falk, 2020, The New England journal of medicine.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Kelley E. Capocelli, J. Sheikh, D. Metz, 2018, Gastroenterology.

Defining the functionally sufficient regulatory region and liver-specific roles of the erythropoietin gene by transgene complementation.

Masayuki Yamamoto, I. Hirano, N. Suzuki, 2021, Life sciences.

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

G. Yancopoulos, N. Stahl, A. Schoepfer, 2019, Gastroenterology.

Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders.

Kelley E. Capocelli, A. Schoepfer, A. Straumann, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis.

K. Nadeau, R. Strieter, I. Hirano, 2015, The Journal of allergy and clinical immunology.

Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.

I. Hirano, N. Gonsalves, A. Ditto, 2012, Gastroenterology.

Treatment of eosinophilic esophagitis: Drugs, diet, or dilation?

I. Hirano, Ameesh Shah, 2007, Current gastroenterology reports.

Molecular, Endoscopic, Histologic and Circulating Biomarker-Based Diagnosis of Eosinophilic Gastritis: Multi-Site Study.

Garrett A. Osswald, Kelley E. Capocelli, E. Dellon, 2019, The Journal of allergy and clinical immunology.

RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis.

G. Opiteck, D. Penenberg, A. Schoepfer, 2019, Gastroenterology.

Qualitative Assessment of Patient-reported Outcomes in Adults With Eosinophilic Esophagitis

D. Burstein, I. Hirano, T. Taft, 2011, Journal of clinical gastroenterology.

Assessing Adherence and Barriers to Long-Term Elimination Diet Therapy in Adults with Eosinophilic Esophagitis

I. Hirano, T. Taft, N. Gonsalves, 2018, Digestive Diseases and Sciences.

Biological therapies for eosinophilic gastrointestinal diseases

I. Hirano, J. Wechsler, 2018, The Journal of allergy and clinical immunology.

The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin

I. Hirano, N. Suzuki, 2019, Front. Cell Dev. Biol..

Medical Nutrition Therapy for Patients With Advanced Systemic Sclerosis (MNT PASS): A Pilot Intervention Study

I. Hirano, P. Sheean, D. Brenner, 2017, JPEN. Journal of parenteral and enteral nutrition.

New Developments in the Diagnosis, Therapy, and Monitoring of Eosinophilic Esophagitis

I. Hirano, R. Patel, 2018, Current Treatment Options in Gastroenterology.

Nrf2 contributes to the weight gain of mice during space travel

Dai Shiba, Masaki Shirakawa, Satoru Takahashi, 2020, Communications Biology.

The 1‐Hour Esophageal String Test: A Non‐Endoscopic Minimally Invasive Test to Accurately Detect Disease Activity in Eosinophilic Esophagitis: 935

Kelley E. Capocelli, I. Hirano, N. Gonsalves, 2019, Journal of Allergy and Clinical Immunology.

Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis.

A. Schoepfer, A. Straumann, E. Dellon, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis

A. Bredenoord, A. Schoepfer, A. Straumann, 2015, Gut.

Eosinophilic esophagitis.

I. Hirano, 2014, Gastroenterology clinics of North America.

T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.

J. Goldblum, James J. Lee, G. Falk, 2014, Gastroenterology.

Eosinophilic esophagitis: Pathophysiology and optimal management

I. Hirano, Carol P. Garrean, 2009, Current gastroenterology reports.

350 Efficacy of Budesonide Oral Suspension for Eosinophilic Esophagitis in Adolescents and Adults: Results From a Phase 3, Randomized, Placebo-Controlled Trial

E. Dellon, G. Falk, I. Hirano, 2019, American Journal of Gastroenterology.

Creating a multi-center rare disease consortium – the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)

Kelley E. Capocelli, J. Krischer, A. Schoepfer, 2017, Translational science of rare diseases.

Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity

M. Zwahlen, J. Woosley, A. Schoepfer, 2015, Alimentary pharmacology & therapeutics.

2015 David Y. Graham Lecture: The First Two Decades Of Eosinophilic Esophagitis—From Acid Reflux To Food Allergy

I. Hirano, 2016, The American Journal of Gastroenterology.

EMERGING THERAPIES FOR EOSINOPHILIC ESOPHAGITIS.

E. Dellon, I. Hirano, T. Greuter, 2019, The Journal of allergy and clinical immunology.

White Paper AGA: Drug Development for Eosinophilic Esophagitis

E. Dellon, S. Spechler, I. Hirano, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.

M. Vaezi, I. Hirano, R. Kavitt, 2016, The American journal of medicine.

Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease.

I. Hirano, J. Sodikoff, 2015, Best practice & research. Clinical gastroenterology.

Low Prevalence of Extraesophageal Gastrointestinal Pathology in Patients with Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, Nancy Ho, 2021, Digestive Diseases and Sciences.

Determination of Biopsy Yield That Optimally Detects Eosinophilic Gastritis and/or Duodenitis in a Randomized Trial of Lirentelimab.

J. Murray, E. Dellon, G. Falk, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Expression of mast cell-associated genes is upregulated in adult eosinophilic esophagitis and responds to steroid or dietary therapy.

I. Hirano, N. Gonsalves, P. Bryce, 2011, The Journal of allergy and clinical immunology.

Chronic Intestinal Pseudo-Obstruction

J. Pandolfino, I. Hirano, 2000, Digestive Diseases.

Manometric features of eosinophilic esophagitis in esophageal pressure topography

J. Pandolfino, S. Roman, P. Kahrilas, 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.

S. Aceves, I. Hirano, 2014, Gastroenterology clinics of North America.

Epidemiology and implications of concurrent diagnosis of eosinophilic oesophagitis and IBD based on a prospective population-based analysis

I. Hirano, J. Colombel, S. Shah, 2019, Gut.

American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection.

Siddharth Singh, Y. Falck‐Ytter, I. Hirano, 2017, Gastroenterology.

An anti-IL-13 antibody reverses epithelial-mesenchymal transition biomarkers in eosinophilic esophagitis: phase 2 trial results.

Nathan P. McMahon, E. Dellon, I. Hirano, 2020, The Journal of allergy and clinical immunology.

New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

E. Dellon, T. Platts-Mills, S. Aceves, 2018, The Journal of allergy and clinical immunology.

Eosinophilic gastrointestinal diseases—clinically diverse and histopathologically confounding

S. Aceves, I. Hirano, M. Collins, 2012, Seminars in Immunopathology.

Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders

J. Krischer, E. Dellon, G. Falk, 2019, Digestive Diseases and Sciences.

Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again.

I. Hirano, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Practical approach to implementing dietary therapy in adults with eosinophilic esophagitis: the Chicago experience.

I. Hirano, N. Gonsalves, P. Bryce, 2015, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study

Y. Fernández-Marrero, A. Schoepfer, A. Straumann, 2022, Allergy.

Clinical relevance of esophageal subepithelial activity in eosinophilic esophagitis

I. Hirano, 2019, Journal of Gastroenterology.

Development and field testing of a novel patient‐reported outcome measure of dysphagia in patients with eosinophilic esophagitis

E. Dellon, I. Hirano, A. Irani, 2013, Alimentary pharmacology & therapeutics.

Eosinophilic gastrointestinal diseases—clinically diverse and histopathologically confounding

S. Aceves, I. Hirano, M. Collins, 2012, Seminars in Immunopathology.

GATA2 hypomorphism induces chronic myelomonocytic leukemia in mice

Masayuki Yamamoto, I. Hirano, Atsushi Hasegawa, 2019, Cancer science.

Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.

E. Dellon, G. Falk, S. Aceves, 2019, Gastroenterology.

Late‐onset MNGIE due to partial loss of thymidine phosphorylase activity

A. V. van Kuilenburg, A. Buchman, J. Verschuuren, 2005, Annals of neurology.

Editorial: long‐term effectiveness of elimination diet therapy for eosinophilic oesophagitis—is the glass half full or half empty?

I. Hirano, N. Gonsalves, 2018, Alimentary pharmacology & therapeutics.

2 Nonvariceal Esophageal Bleeding

I. Hirano, C. Stevoff, Christian G. Stevoff, 2017 .

Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial.

A. Schoepfer, E. Dellon, G. Falk, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Budesonide Oral Suspension Improves Outcomes in Patients With Eosinophilic Esophagitis: Results from a Phase 3 Trial.

E. Dellon, G. Falk, I. Hirano, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.

Kenneth K Wang, Y. Falck‐Ytter, I. Hirano, 2020, Gastroenterology.

Improvements in Dysphagia and Pain With Swallowing in Patients With Eosinophilic Esophagitis Receiving Budesonide Oral Suspension.

E. Dellon, I. Hirano, D. Katzka, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

J. Krischer, E. Dellon, G. Falk, 2018, The lancet. Gastroenterology & hepatology.

Nonvariceal Esophageal Bleeding

I. Hirano, C. Stevoff, Christian G. Stevoff, 2003 .

Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations

S. Dimauro, I. Nonaka, I. Nishino, 2000, Annals of neurology.

Endoscopic approach to eosinophilic esophagitis: American Society for Gastrointestinal Endoscopy Consensus Conference.

V. Konda, T. Baron, A. Schoepfer, 2022, Gastrointestinal endoscopy.

Approaches and Challenges to Management of Pediatric and Adult Patients With Eosinophilic Esophagitis.

I. Hirano, G. Furuta, 2019, Gastroenterology.

Oral delivery of fluticasone powder improves esophageal eosinophilic inflammation and symptoms in adults with eosinophilic esophagitis.

A. Straumann, I. Hirano, N. Gonsalves, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Clinical and manometric features of the lower esophageal muscular ring

R. Goyal, I. Hirano, J. Gilliam, 2000, American Journal of Gastroenterology.

Distinguishing GERD from eosinophilic oesophagitis: concepts and controversies

I. Hirano, L. Kia, 2015, Nature Reviews Gastroenterology &Hepatology.

Clinical Guideline : Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis ( EoE )

E. Dellon, I. Hirano, D. Katzka, 2013 .

Advances in diagnostic testing for gastroesophageal reflux disease.

I. Hirano, A. Gawron, 2010, World journal of gastroenterology.

A mouse model of adult-onset anaemia due to erythropoietin deficiency

Masayuki Yamamoto, I. Hirano, N. Minegishi, 2013, Nature Communications.

American Gastroenterological Association Institute Guideline on the Management of Acute Diverticulitis.

I. Hirano, N. Stollman, W. Smalley, 2015, Gastroenterology.

Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis.

J. Pandolfino, P. Kahrilas, I. Hirano, 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Functional luminal imaging probe topography: an improved method for characterizing esophageal distensibility in eosinophilic esophagitis

Ikuo Hirano, Zhiyue Lin, Yinglian Xiao, 2013, Therapeutic advances in gastroenterology.

Pediatric and adult eosinophilic esophagitis: similarities and differences

A. Schoepfer, A. Straumann, H. Simon, 2012, Allergy.

Eosinophilic esophagitis: updated consensus recommendations for children and adults.

A. Schoepfer, A. Straumann, N. Shaheen, 2011, The Journal of allergy and clinical immunology.

Mechanical properties of the esophagus in eosinophilic esophagitis.

Ikuo Hirano, Peter J Kahrilas, John E Pandolfino, 2011, Gastroenterology.

Esophageal Microbiome in Eosinophilic Esophagitis

N. Pace, J. Harris, R. Fang, 2015, PloS one.

AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.

Kenneth K Wang, I. Hirano, N. Stollman, 2020, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Esophageal Dilation in Eosinophilic Esophagitis: Effectiveness, Safety, and Impact on the Underlying Inflammation

A. Schoepfer, A. Straumann, H. Simon, 2010, The American Journal of Gastroenterology.

Erythropoietin Synthesis in Renal Myofibroblasts Is Restored by Activation of Hypoxia Signaling.

S. Ito, K. Takeda, A. Nishiyama, 2016, Journal of the American Society of Nephrology : JASN.

Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.

E. Dellon, I. Hirano, D. Katzka, 2017, Gastroenterology.

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis.

M. Zwahlen, J. Woosley, T. Smyrk, 2016, Gastroenterology.

Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

M. Zwahlen, A. Schoepfer, A. Straumann, 2014, Gastroenterology.

Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system

M. Heckman, I. Hirano, N. Gonsalves, 2012, Gut.

Long-Term Treatment of Eosinophilic Esophagitis with Budesonide Oral Suspension.

E. Dellon, G. Falk, R. Fogel, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Epidemiology and Natural History of Eosinophilic Esophagitis.

E. Dellon, I. Hirano, 2017, Gastroenterology.

Evaluation of esophageal distensibility in eosinophilic esophagitis: an update and comparison of functional lumen imaging probe analytic methods

J. Pandolfino, I. Hirano, D. Carlson, 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

953 Safety and Efficacy of Oral Budesonide Suspension for Maintenance Therapy in Eosinophilic Esophagitis: Results From a Prospective Open-Label Study of Adolescents and Adults

E. Dellon, I. Hirano, D. Katzka, 2016 .

Proton pump inhibitor-responsive esophageal eosinophilia does not preclude food-responsive eosinophilic esophagitis.

I. Hirano, J. Sodikoff, 2016, The Journal of allergy and clinical immunology.

Clinical outcomes of adults with eosinophilic esophagitis with severe stricture.

I. Hirano, N. Gonsalves, D. Gregory, 2020, Gastrointestinal endoscopy.

How I Approach the Management of Eosinophilic Esophagitis in Adults

I. Hirano, 2017, The American Journal of Gastroenterology.

Severity of endoscopically identified esophageal rings correlates with reduced esophageal distensibility in eosinophilic esophagitis

J. Pandolfino, P. Kahrilas, I. Hirano, 2016, Endoscopy.

Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis

A. Schoepfer, G. Falk, I. Hirano, 2020, Alimentary pharmacology & therapeutics.

Dilation in eosinophilic esophagitis: to do or not to do?

I. Hirano, 2010, Gastrointestinal endoscopy.

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

A. Bredenoord, A. Schoepfer, A. Straumann, 2022, Gastroenterology.

A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.

A. Bredenoord, A. Schoepfer, A. Straumann, 2022, The Journal of allergy and clinical immunology.

Improvement in Esophageal Distensibility in Response to Medical and Diet Therapy in Eosinophilic Esophagitis

J. Pandolfino, I. Hirano, D. Carlson, 2017, Clinical and Translational Gastroenterology.

Quality Indicators for the Diagnosis and Management of Eosinophilic Esophagitis.

A. Bredenoord, E. Dellon, G. Falk, 2023, The American journal of gastroenterology.

Editorial: cooking up something new for diet therapy of eosinophilic oesophagitis

I. Hirano, L. Almassalha, 2022, Alimentary pharmacology & therapeutics.

AJG-22-0145 1963..1970

I. Hirano, N. Gonsalves, A. Krause, 2022 .

AJG-21-0877 264..271

A. Bredenoord, E. Dellon, I. Hirano, 2022 .

Evaluation of Esophageal Motility Utilizing the Functional Lumen Imaging Probe

J. Pandolfino, P. Kahrilas, I. Hirano, 2016, The American Journal of Gastroenterology.

Safety and Efficacy of Budesonide Oral Suspension Maintenance Therapy in Patients With Eosinophilic Esophagitis

E. Dellon, I. Hirano, D. Katzka, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Food allergy and gastrointestinal disease Alignment of parent-and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites

J. Krischer, E. Dellon, G. Falk, 2018 .

Editorial: oesophageal dilation in eosinophilic oesophagitis—can and should, but when and how?

I. Hirano, L. Kia, 2017, Alimentary pharmacology & therapeutics.

Eosinophilic esophagitis: overview of clinical management.

A. Schoepfer, I. Hirano, D. Katzka, 2014, Gastroenterology clinics of North America.

Food‐induced immediate response of the esophagus—A newly identified syndrome in patients with eosinophilic esophagitis

A. Bredenoord, A. Schoepfer, A. Straumann, 2020, Allergy.

How Do Gastroenterologists Assess Overall Activity of Eosinophilic Esophagitis in Adult Patients?

G. Petris, M. Zwahlen, J. Woosley, 2015, American Journal of Gastroenterology.

Endoscopic assessment of eosinophilic esophagitis

I. Hirano, R. Kavitt, 2014 .

Editorial: Should Patients With Suspected Eosinophilic Esophagitis Undergo a Therapeutic Trial of Proton Pump Inhibition?

I. Hirano, 2013, The American Journal of Gastroenterology.

Eosinophilic Esophagitis: Interactions with Gastroesophageal Reflux Disease

I. Hirano, K. Krishnan, 2013 .

Pathophysiology of achalasia

I. Hirano, 1999, Current gastroenterology reports.

Deglutitive inhibition affects both esophageal peristaltic amplitude and shortening.

J. Pandolfino, P. Kahrilas, I. Hirano, 2003, American journal of physiology. Gastrointestinal and liver physiology.

Histopathologic Variability in Children With Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, H. Melín‐Aldana, 2009, The American Journal of Gastroenterology.

Functional Lumen Imaging Probe for the Management of Esophageal Disorders: Expert Review From the Clinical Practice Updates Committee of the AGA Institute

G. Boeckxstaens, J. Pandolfino, I. Hirano, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Comparison of endoscopy and radiographic imaging for detection of esophageal inflammation and remodeling in adults with eosinophilic esophagitis.

F. Miller, I. Hirano, N. Gonsalves, 2017, Gastrointestinal endoscopy.

Achalasia treatment: improved outcome of laparoscopic myotomy with operative manometry.

J. Pandolfino, P. Kahrilas, I. Hirano, 2004, Archives of surgery.

Eosinophilic esophagitis: are we just scratching the surface?

I. Hirano, Meena A. Prasad, 2013, Gastroenterology & hepatology.

Review article: modern technology in the diagnosis of gastro‐oesophageal reflux disease – Bilitec, intraluminal impedance and Bravo capsule pH monitoring

I. Hirano, 2006, Alimentary pharmacology & therapeutics.

Temporal trends in the relative prevalence of dysphagia etiologies from 1999-2009.

I. Hirano, T. Taft, Nancy Ho, 2012, World journal of gastroenterology.

Manometric heterogeneity in patients with idiopathic achalasia.

P. Kahrilas, I. Hirano, R. Joehl, 2001, Gastroenterology.

Conjunctivitis in dupilumab clinical trials

John D. Davis, C. Bachert, P. Asbell, 2019, The British journal of dermatology.

"Imaging Findings of Eosinophilic Gastrointestinal Diseases in Adults".

F. Miller, I. Hirano, L. Kelahan, 2022, Current problems in diagnostic radiology.

Esophagus: Anatomy and Developmental and Structural Anomalies

I. Hirano, 2009 .

Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.

Garrett A. Osswald, E. Dellon, G. Falk, 2021, Gastroenterology.

Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders

N. Lewis, E. Dellon, S. Aceves, 2020, Journal of pediatric gastroenterology and nutrition.

Heterozygous variants in GATA2 contribute to DCML deficiency in mice by disrupting tandem protein binding

I. Hirano, Atsushi Hasegawa, R. Shimizu, 2022, Communications Biology.

[A case of toxic shock syndrome].

I. Hirano, H. Igarashi, Y. Naide, 1986, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

Prospective assessment of the diagnostic utility of esophageal brushings in adults with eosinophilic esophagitis.

I. Hirano, T. Taft, N. Gonsalves, 2016, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

727 A Prospective Clinical Trial of Six Food Elimination Diet and Reintroduction of Causative Agents in Adults with Eosinophilic Esophagitis (EE)

I. Hirano, N. Gonsalves, A. Ditto, 2008 .

Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis—a Systematic Review and Meta-analysis

R. Peek, I. Hirano, J. Colombel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials

E. Dellon, I. Hirano, D. Katzka, 2023, Alimentary pharmacology & therapeutics.

How to Approach a Patient With Eosinophilic Esophagitis.

I. Hirano, 2018, Gastroenterology.

EFFeCtiveness AND SAFETY OF High versus low dose swallowed TopICal STEROIDs for Maintenance Treatment of Eosinophilic Esophagitis: A Multi-Center Observational Study.

A. Schoepfer, A. Straumann, E. Dellon, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

One-Hour Esophageal String Test: A Nonendoscopic Minimally Invasive Test That Accurately Detects Disease Activity in Eosinophilic Esophagitis

James J. Lee, I. Hirano, N. Gonsalves, 2019, The American journal of gastroenterology.

Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet?

E. Dellon, G. Falk, S. Aceves, 2016, The Journal of allergy and clinical immunology.

Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children

I. Hirano, B. Wershil, J. Wechsler, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial.

John A. Besse, J. Krischer, E. Dellon, 2023, The lancet. Gastroenterology & hepatology.

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.

A. Bredenoord, G. Yancopoulos, E. Dellon, 2022, The New England journal of medicine.

Clinical Guidance for the Use of Dupilumab in Eosinophilic Esophagitis: A Yardstick.

E. Dellon, S. Aceves, I. Hirano, 2022, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Eosinophilic Esophagitis: Treatment Approach in Adults

I. Hirano, 2012 .

Diversion Colitis in Patients with Myelopathy: Clinical, Endoscopic, and Histopathological Findings

D. Soybel, I. Hirano, N. Ahmed, 2000, The journal of spinal cord medicine.

International consensus recommendations for eosinophilic gastrointestinal disease nomenclature.

Joy W. Chang, Lisa J. Martin, D. Metz, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Diet therapy for eosinophilic esophagitis: when, why and how

I. Hirano, R. Vashi, 2013, Current opinion in gastroenterology.

Sustained Remission Following Six Food Elimination Diet (SFED) and Reintroduction Among Adults with EOE

I. Hirano, N. Gonsalves, Guang-Yu Yang, 2017 .

Budesonide Oral Suspension Significantly Improves Eosinophilic Esophagitis Histology Scoring System Results

E. Dellon, I. Hirano, D. Katzka, 2019, The American journal of surgical pathology.

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

G. Guyatt, J. Sheikh, M. Zwahlen, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Sa1151 - Baseline Characteristics and Correlation Between Dysphagia and Disease Activity in Patients with Eosinophilic Esophagitis in a Randomized, Placebo-Controlled, Phase 2 Dupilumab Trial

A. Schoepfer, E. Dellon, G. Falk, 2018 .

Measuring esophageal compliance using functional lumen imaging probe to assess remodeling in eosinophilic esophagitis

J. Pandolfino, I. Hirano, D. Carlson, 2023, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis

Lisa J. Martin, E. Dellon, G. Falk, 2021, The American journal of gastroenterology.

AJG-21-1701 272..279

E. Dellon, G. Falk, N. Arva, 2022 .

877 Prospective Trial of Four Food Elimination Diet Demonstrates Comparable Effectiveness in the Treatment of Adult and Pediatric Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, B. Wershil, 2013 .

The adult eosinophilic oesophagitis quality of life questionnaire: a new measure of health‐related quality of life

I. Hirano, T. Taft, L. Keefer, 2011, Alimentary pharmacology & therapeutics.

Summary of the updated international consensus diagnostic criteria for eosinophilic esophagitis: AGREE conference.

A. Bredenoord, E. Dellon, I. Hirano, 2018, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Esophageal Hypervigilance and Symptom Specific Anxiety in Patients with Eosinophilic Esophagitis.

J. Pandolfino, I. Hirano, D. Carlson, 2021, Gastroenterology.

EUS and histopathologic correlates in eosinophilic esophagitis.

P. Kahrilas, I. Hirano, W. Parsons, 2001, Gastrointestinal endoscopy.

Changes in Esophageal Distensibility Associated with Treatment Response in Eosinophilic Esophagitis: A Study Utilizing the Functional Lumen Imaging Probe

J. Pandolfino, I. Hirano, D. Carlson, 2017 .

Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms Following Dilation in Adults with Eosinophilic Esophagitis.

Lisa J. Martin, A. Schoepfer, E. Dellon, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prospective assessment of disease-specific quality of life in adults with eosinophilic esophagitis.

I. Hirano, T. Taft, N. Gonsalves, 2018, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Management of eosinophilic esophagitis associated food impaction in Europe and the United States.

Joy W. Chang, A. Bredenoord, A. Schoepfer, 2022, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Clinical Features at Baseline Cannot Predict Symptom Response to Placebo in Patients With Eosinophilic Esophagitis.

E. Dellon, I. Hirano, D. Katzka, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

S1088 Duration of Dysphagia is Associated With Increased Frequency of Dysphagia and Food Impaction in Adults With Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, M. Kwasny, 2010 .

S1081 Patient Reported Outcomes in Adults With Eosinophilic Esophagitis

I. Hirano, T. Taft, N. Gonsalves, 2010 .

Nrf2 contributes to the weight gain of mice during space travel

Dai Shiba, Masaki Shirakawa, Takafumi Suzuki, 2020, Communications Biology.

Ambulatory pH Monitoring: New Advances and Indications.

I. Hirano, Brant J. Lutsi, 2006, Gastroenterology & hepatology.

Four-day Bravo pH capsule monitoring with and without proton pump inhibitor therapy.

Ikuo Hirano, Peter J Kahrilas, John E Pandolfino, 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers

A. Suzuki, Masayuki Yamamoto, A. Miyajima, 2013, Molecular and Cellular Biology.

Dupilumab Reduces Biomarkers of Type 2 Inflammation in Adult and Adolescent Patients With Eosinophilic Esophagitis: Results From Parts A and C of a Three-Part, Phase 3 LIBERTY EoE TREET Study

A. Schoepfer, E. Dellon, I. Hirano, 2022, Journal of Allergy and Clinical Immunology.

Plasticity of renal erythropoietin-producing cells governs fibrosis.

S. Ito, Masayuki Yamamoto, I. Hirano, 2013, Journal of the American Society of Nephrology : JASN.

Application of the Functional Lumen Imaging Probe to Esophageal Disorders

I. Hirano, D. Carlson, 2017, Current Treatment Options in Gastroenterology.

Title Evaluation of Esophageal Motility Utilizing the Functional LumenImaging Probe

P. Kahrilas, I. Hirano, D. Carlson, 2016 .

Diminished mechanosensitivity and chemosensitivity in patients with achalasia.

I. Hirano, G. Shi, Stephen P. Brackbill, 2003, American journal of physiology. Gastrointestinal and liver physiology.

AGA Gastroenterology Training Exam (GTE): a progress report.

R. Stansfield, J. Fitzgerald, I. Hirano, 2012, Gastroenterology.

Retrograde gastric intussusception after myotomy for achalasia.

M. Blum, I. Hirano, M. Ujiki, 2006, Annals of Thoracic Surgery.

Upper Gastrointestinal Tract

I. Hirano, J. Clarke, 2012 .

Dysphagia Days as an Assessment of Clinical Treatment Outcome in Eosinophilic Esophagitis

K. Coyne, E. Dellon, I. Hirano, 2022, The American journal of gastroenterology.

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

A. Schoepfer, A. Straumann, E. Dellon, 2018, Annals of Allergy, Asthma & Immunology.

Editorial: Reflux While Running: Something to Belch About

I. Hirano, D. Carlson, 2016, The American Journal of Gastroenterology.

High Patient Disease Burden in a Cross-sectional, Multicenter Contact Registry Study of Eosinophilic Gastrointestinal Diseases

J. Krischer, E. Dellon, G. Falk, 2020, Journal of pediatric gastroenterology and nutrition.

Impact on Health-Related Quality of Life in Adults with Eosinophilic Gastritis and Gastroenteritis: A Qualitative Assessment

I. Hirano, T. Taft, N. Gonsalves, 2018, Digestive Diseases and Sciences.

Editorial: expanding a narrow perspective on narrow calibre oesophagus in eosinophilic oesophagitis

I. Hirano, J. Molina-Infante, 2015, Alimentary pharmacology & therapeutics.

Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?

I. Hirano, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Mucosal Microbiota Associated With Eosinophilic Esophagitis and Eosinophilic Gastritis

Nicoleta C. Arva, J. Harris, E. Dellon, 2022, Journal of pediatric gastroenterology and nutrition.

Long‐Term Efficacy and Safety of RPC4046, an Anti‐Interleukin‐13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open‐Label Extension of the HEROES Study: 632

G. Opiteck, A. Schoepfer, A. Straumann, 2019, Journal of Allergy and Clinical Immunology.

876 - Sustained Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients with Eosinophilic Esophagitis: Results from the Open-Label Extension of the Heroes Study

G. Opiteck, A. Schoepfer, A. Straumann, 2018 .

S1971 Comparison of Demographic, Endoscopic and Histologic Features in EoE Patients with and Without GERD

I. Hirano, N. Gonsalves, Carol P. Garrean, 2008 .

ALIMENTARY TRACT Esophageal Distensibility as a Measure of Disease Severity in Patients With Eosinophilic Esophagitis

J. Pandolfino, P. Kahrilas, I. Hirano, 2013 .

Working with the US Food and Drug Administration: progress and timelines in understanding and treating patients with eosinophilic esophagitis.

A. Straumann, S. Aceves, I. Hirano, 2012, The Journal of allergy and clinical immunology.

Role of Advanced Diagnostics for Eosinophilic Esophagitis

I. Hirano, 2014, Digestive Diseases.

Eosinophilic Esophagitis: Etiology and Therapy.

I. Hirano, N. Gonsalves, R. Patel, 2020, Annual review of medicine.

Mast cell‐pain connection in eosinophilic esophagitis

E. Dellon, G. Falk, N. Arva, 2022, Allergy.

Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial

J. Woosley, A. Iuga, E. Dellon, 2023, Gut.

Long-Term Outcomes of the Six-Food Elimination Diet and Food Reintroduction in a Large Cohort of Adults With Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, A. Krause, 2022, The American journal of gastroenterology.

Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis

A. Bredenoord, E. Dellon, I. Hirano, 2021, The American journal of gastroenterology.

Conjunctivitis in dupilumab clinical trials

C. Bachert, P. Asbell, M. Cork, 2019, British Journal of Dermatology.

Sa1118 - Eosinophilic Esophagitis-Like Disease with Lack of Significant Esophageal Eosinophilia: Description of a New Disease Entity

A. Schoepfer, A. Straumann, E. Dellon, 2018 .

Prospective study of an amino acid-based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial.

S. Aceves, I. Hirano, N. Gonsalves, 2023, The Journal of allergy and clinical immunology.

An Overview of Dietary Therapies for the Treatment of Eosinophilic Esophagitis.

I. Hirano, 2017, Gastroenterology & hepatology.

Long Term Maintenance Therapy With Dietary Restriction in Adults With Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, B. Doerfler, 2011 .

A Randomized, Double-Blind, Placebo-Controlled Trial of a Fluticasone Propionate Orally Disintegrating Tablet in Adult and Adolescent Patients with Eosinophilic Esophagitis: A Phase 1/2A Safety and Tolerability Study

A. Schoepfer, G. Falk, I. Hirano, 2017 .

Use of a continuing medical education course to improve fellows' knowledge and skills in esophageal disorders.

J. Pandolfino, I. Hirano, S. Komanduri, 2011, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

610 EFFICACY AND SAFETY OF BENRALIZUMAB IN ADULTS AND ADOLESCENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE 24-WEEK DOUBLE-BLIND PERIOD OF THE PHASE 3 MESSINA TRIAL

A. Bredenoord, E. Dellon, I. Hirano, 2023, Gastroenterology.

S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE

I. Hirano, D. Leiman, R. Genta, 2022, American Journal of Gastroenterology.

Drugs activating hypoxia-inducible factors correct erythropoiesis and hepcidin levels via renal EPO induction in mice

I. Hirano, Y. Tomioka, N. Suzuki, 2023, Blood advances.

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial.

R. Sampliner, D. Ahnen, R. Goyal, 2001, JAMA.

AJG-21-0760 413..423

E. Dellon, G. Falk, S. Aceves, 2022 .

Cytomegalovirus Infection Associated with Esophagitis and Esophageal Stricture after Liver Transplantation: 549

I. Hirano, Joseph C. Ahn, F. Steven, 2007 .

Clinical Guideline : Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis ( EoE )

E. Dellon, I. Hirano, D. Katzka, 2013 .

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

M. Zwahlen, J. Woosley, T. Smyrk, 2015, The American journal of gastroenterology.

Dupilumab Improves Health-Related Quality of Life (HRQoL) and Reduces Symptom Burden in Patients with Eosinophilic Esophagitis (EoE): Results From Part A of a Randomized, Placebo-Controlled Three-Part Phase 3 Study

A. Bredenoord, E. Dellon, I. Hirano, 2021 .

Evaluating Eosinophilic Colitis as a Unique Disease using Colonic Molecular Profiles: A Multi-Site Study.

Garrett A. Osswald, E. Dellon, G. Falk, 2022, Gastroenterology.

229 RESULTS FROM THE ELEMENT STUDY: PROSPECTIVE STUDY OF ELEMENTAL DIET IN EOSINOPHILIC GASTROENTERITIS NUTRITION TRIAL

Lisa J. Martin, S. Aceves, I. Hirano, 2020 .

The enteric nervous system.

R. Goyal, I. Hirano, R. K. Goyal, 1996, The New England journal of medicine.

Eosinophilic Esophagitis (EE) in Adults: Emerging Entity or Misdiagnosed Malady

P. Kahrilas, I. Hirano, N. Gonsalves, 2005 .

Eosinophilic Esophagitis: A Clinico-Pathological Disease?

I. Hirano, 2014 .

Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.

A. Bredenoord, E. Dellon, I. Hirano, 2023, The lancet. Gastroenterology & hepatology.

How do gastroenterologists assess overall activity of eosinophilic esophagitis in adult patients?

M. Zwahlen, J. Woosley, T. Smyrk, 2015, American Journal of Gastroenterology.

Mo1861 Development of a Symptom-Based Activity Index for Eosinophilic Esophagitis

M. Zwahlen, A. Schoepfer, A. Straumann, 2014 .

Inter-Observer Agreement on Endoscopic Esophageal Findings in Eosinophilic Esophagitis (EoE)

M. Heckman, I. Hirano, N. Gonsalves, 2011 .

Natural History of Eosinophilic Esophagitis

E. Dellon, D. Johnson, I. Hirano, 2018 .

S1094 Limited Accuracy of Upper GI Studies in the Diagnosis of Eosinophilic Esophagitis in Adults

F. Miller, I. Hirano, N. Moy, 2010 .

S1864 The Utility of Specific Symptoms and Endoscopic Features As Predictors of Eosinophilic Esophagitis (EoE) in Adults

I. Hirano, N. Gonsalves, J. Kim, 2009 .

S1860 Comparison of Endoscopic and Histologic Response in Patients with Eosinophilic Esophagitis Treated with Proton Pump Inhibition, Topical Fluticasone, and Dietary Elimination

Deepa T. Patil, I. Hirano, N. Gonsalves, 2009 .

S1983 Narrow Band Imaging May Improve the Sensitivity of Endoscopy for Diagnosing Eosinophilic Esophagitis

I. Hirano, N. Gonsalves, S. Eswaran, 2008 .

Reliability and Responsiveness of Endoscopic Disease Activity Assessment in Eosinophilic Esophagitis.

A. Bredenoord, A. Schoepfer, A. Straumann, 2022, Gastrointestinal endoscopy.

Prospective Endoscopic Activity Assessment for Eosinophilic Gastritis in a Multisite Cohort

E. Dellon, G. Falk, S. Aceves, 2022, The American journal of gastroenterology.

Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target?

I. Hirano, David Katzka, David A Katzka, 2023, Gut.

ALIMENTARY TRACT Long-term Efﬁcacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis

A. Schoepfer, A. Straumann, E. Dellon, 2021 .

A mouse model of adult-onset anaemia due to erythropoietin deficiency

Masayuki Yamamoto, I. Hirano, N. Minegishi, 2013, Nature Communications.

Nrf2 Enhances Cholangiocyte Expansion in Pten-Deficient Livers

A. Suzuki, Masayuki Yamamoto, A. Miyajima, 2013, Molecular and Cellular Biology.

Pediatric and adult eosinophilic esophagitis: similarities and differences

A. Schoepfer, A. Straumann, H. Simon, 2012, Allergy.

Characterization of Eosinophilic Esophagitis Murine Models Using Optical Coherence Tomography References and Links

R. D. Ferguson, J. Glessner, H. Hakonarson, 2022 .

Manometric features of eosinophilic esophagitis in esophageal pressure topography

J. Pandolfino, P. Kahrilas, I. Hirano, 2011, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Bulk T‐cell receptor sequencing confirms clonality in pediatric eosinophilic esophagitis and identifies a food‐specific repertoire

I. Hirano, N. Gonsalves, B. Wershil, 2023, Allergy.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Nicoleta C. Arva, J. Sheikh, D. Metz, 2018, Gastroenterology.

ACG Clinical Guideline: Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis (EoE)

E. Dellon, I. Hirano, N. Gonsalves, 2013, The American Journal of Gastroenterology.

Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors.

I. Hirano, N. Gonsalves, A. Ditto, 2012, Gastroenterology.

Clinical Reviews in Allergy and Immunology Eosinophilic Esophagitis: Updated Consensus Recommendations for Children and Adults

A. Schoepfer, A. Straumann, R. Odze, 2022 .

American Gastroenterological Association Institute Guideline on the Management of Crohn's Disease After Surgical Resection.

Siddharth Singh, I. Hirano, E. Loftus, 2017, Gastroenterology.

Pooled Phase 2 and 3 Efficacy and Safety Data on Budesonide Oral Suspension in Adolescents with Eosinophilic Esophagitis

E. Dellon, G. Falk, I. Hirano, 2023, Journal of pediatric gastroenterology and nutrition.

Su1173: EFFECT OF PRIOR ESOPHAGEAL DILATION ON HISTOLOGIC, SYMPTOM AND ENDOSCOPIC OUTCOMES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: POST HOC ANALYSIS FROM A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF BUDESONIDE ORAL SUSPENSION

E. Dellon, G. Falk, I. Hirano, 2022, Gastroenterology.

Monitoring patients with eosinophilic esophagitis in routine clinical practice - International Expert Recommendations.

M. Vieth, A. Bredenoord, A. Schoepfer, 2022, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Spotlight: Treatment of Eosinophilic Esophagitis (EoE).

Kenneth K Wang, I. Hirano, R. Sharaf, 2020, Gastroenterology.

Comparison of endoscopy and radiographic imaging for detection of esophageal inflammation and remodeling in adults with eosinophilic esophagitis.

F. Miller, I. Hirano, N. Gonsalves, 2017, Gastrointestinal endoscopy.

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study

A. Bredenoord, I. Hirano, A. Shabbir, 2023, Gut.

Acid Reflux Detection and Symptom-Reflux Association Using 4-Day Wireless pH Recording Combining 48-Hour Periods Off and On PPI Therapy

I. Hirano, Qing Zhang, N. Gonsalves, 2008, The American Journal of Gastroenterology.

The evolving role of the wireless pH capsule in evaluation of patients with GERD

I. Hirano, Carol P. Garrean, 2007 .

New developments in patients with eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERS Symposium at the 2018 American Academy of Allergy, Asthma & Immunology Meeting.

E. Dellon, T. Platts-Mills, S. Aceves, 2018, The Journal of allergy and clinical immunology.

1244 Symptomatic Patients Suspected of Eosinophilic Gastritis and/or Enteritis Have Elevated Mucosal Mast Cell Counts Without Eosinophilia: A New Diagnostic Entity?

J. Murray, E. Dellon, G. Falk, 2019, American Journal of Gastroenterology.

Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.

A. Bredenoord, I. Hirano, J. Caldwell, 2024, The New England journal of medicine.

Nrf2 alleviates spaceflight-induced immunosuppression and thrombotic microangiopathy in mice

Dai Shiba, Masaki Shirakawa, Takafumi Suzuki, 2023, Communications biology.

Tapinarof Validates the Aryl Hydrocarbon Receptor as a Therapeutic Target: A Clinical Review.

I. Hirano, M. Boguniewicz, P. Brown, 2023, The Journal of allergy and clinical immunology.